《新股消息》名創優品(09896.HK)今起招股 入場費4,464.55元
來港雙重第一上市的名創優品(09896.HK)(MNSO.US)公布招股詳情,擬全球發售4,110萬股,香港公開發售佔一成,國際發售佔九成,每股招股價最高22.1元,每手200計,一手入場費4,464.55元。該股今日(6月30日)起招股,下周三(7月6日)中午截止,預期7月13日掛牌。聯席保薦人為美銀證券、海通國際及瑞銀。
名創優品於2020年10月在美國上市,集團表示,《外國公司問責法案》下美國存託股份存在被除牌風險,但目前並未被美國證監會根據HFCAA及其實施規則認定為被認定的發行人。美股昨晚下跌10.7%收報7.79美元,以每股美國存託股份可轉換為4股普通股計算,港股招股價最高溢價達44%。
公司上市料淨集資約8.02億元,預計約25%用於門店網絡擴張和升級;約20%用於供應鏈優化和產品開發;約20%用於增強技術能力;約20%將繼續投資於品牌推廣及培育;約5%用於資本開支,其中可能包括收購或投資與業務互補的業務或資產;約10%用於營運資金和一般公司用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.